Exhibit 10.8
EMPLOYMENT
AGREEMENT
(Brian Posner)
This Employment Agreement dated as
of January 5, 2009 (this “ Agreement ”) is
made by and between Power Medical Interventions, Inc., a
Delaware corporation (the “ Company ”), and
Brian Posner (“ Executive ”).
BACKGROUND
The Company desires to employ
Executive, and employee desires to be employed by the Company in
accordance with the terms and conditions set forth in this
Agreement.
NOW, THEREFORE, in consideration of
the premises, the respective covenants and commitments of the
parties hereto set forth in this Agreement and for other good and
valuable consideration, the receipt and adequacy of which are
hereby acknowledged, the parties hereto agree as
follows:
1.
Employment
. The
Company offers and Executive accepts employment and agrees to
perform services for the Company, for the period and upon the other
terms and subject to the conditions set forth in this
Agreement.
2.
Employment
Term . Executive’s
employment pursuant to this Agreement shall be from January 5,
2009 (the “ Effective Date ”), through
December 31, 2011, unless earlier terminated pursuant to the
provisions of Section 9 below. If Executive’s
employment continues beyond December 31, 2011, such employment
shall be at will, unless and to the extent this Agreement is
extended or renewed by a written agreement between the
parties.
3.
Title and
Duties; Representations and Warranties .
3.1.
Service With
Company . Company hereby
employs Executive to perform those executive duties and services as
the Company shall from time to time set forth, and Executive
accepts employment with the Company, upon the terms and conditions
hereinafter set forth. Executive shall serve as the Chief
Financial Officer of the Company and shall report to the Chief
Executive Officer of the Company. Executive may also serve as
an officer or director of one or more subsidiaries of the Company;
provided , however, that Executive shall not be entitled to
any additional compensation for serving in such additional
capacities.
3.2.
Performance of
Duties . Executive agrees to
serve the Company faithfully and to the best of his ability and to
devote his full time, attention and best efforts to the business
and affairs of the Company after the Effective Date and during the
term of this Agreement. Except to the extent the restrictions
contained in Section 5 may apply, nothing in this Agreement
shall prohibit Executive from (i) making and managing passive
investments, and (ii) engaging in religious, academic,
charitable or other community or non-profit activities, in a
manner, and to an extent, that will not interfere with his duties
to the Company. Notwithstanding anything to the contrary in this
Section, Company acknowledges the Separation Agreement dated
December 23, 2008 by and among Executive,
Pharmacopeia, Inc. and Ligand Pharmaceuticals Incorporated
and
acknowledges
Executive’ continuing obligations thereunder, including the
obligation to provide certain cooperation.
3.3.
Compliance
with Company Policies . Executive agrees that
in the rendering of all services to the Company and in all aspects
of employment hereunder, he shall comply in all material respects
with all directives, policies, standards and regulations from time
to time established by the Company, including without limitation
Section 104 of Company’s Employment Policies and
Procedures Manual, to the extent they are not in conflict with this
Agreement.
3.4.
Other
Obligations .
(a)
Between
Executive and Third Parties . Executive hereby
represents, warrants and agrees: (i) that Executive has the
full right to enter into this Agreement and perform the services
required of him hereunder, without any restriction whatsoever;
(ii) that in the course of performing services hereunder,
Executive will not violate the terms or conditions of any agreement
between him and any third party or infringe or wrongfully
appropriate any patents, copyrights, trade secrets or other
intellectual property rights of any Person anywhere in the world;
(iii) that Executive has not and will not disclose or use
during his employment by the Company any
confidential information that he acquired as a result of any
previous employment or consulting arrangement or under a previous
obligation of confidentiality; and (iv) that Executive has
disclosed to the Company in writing any and all continuing
obligations to previous employers or others that require him not to
disclose any information to the Company.
(b)
Between
Company and Third Parties . Executive
acknowledges that the Company from time to time may have agreements
with other Persons, including the government of the United States
or other countries and agencies thereof, which impose obligations
or restrictions on Company regarding inventions made during the
course of work thereunder or regarding the confidential nature of
such work. Executive agrees to be bound by all such
obligations and restrictions and to take all action necessary to
discharge the obligations of the Company thereunder.
3.5.
Location
. Executive
initially shall be based at the Company’s principal executive
offices in Langhorne, Pennsylvania and shall maintain a residence
within 75 miles of Langhorne.
4.
Compensation
and Benefits .
4.1.
Salary
. Company
shall pay Executive a base salary (“ Salary ”),
payable in equal installments in accordance with Company’s
standard schedule for salary payments to its executive employees,
at an initial annual rate equal to $250,000.
Executive’s Salary shall be reviewed annually by the Chief
Executive Officer and may be increased at the beginning of each
calendar year.
4.2.
Bonus . Executive will be
eligible to participate in Company’s Incentive Compensation
Plan for Senior Managers (the “ Bonus Plan
”). Any bonus awarded under the Bonus Plan for a given
year (“ Plan Bonus ”) will be subject to the
terms and conditions of the Bonus Plan and based on
(i) Company’s performance during such year measured
against one or
2
more Company goals set by
the Chief Executive Officer at the beginning of such year, and
(ii) Executive’s performance during such year measured
against one or more job-specific goals determined by the Chief
Executive Officer and Executive at the beginning of such
year. Executive’s Plan Bonus for a given year will be
targeted at 35% of Salary for such year, subject to approval by the
Compensation Committee of the Board of Directors (the “
Compensation Committee ”).
4.3.
Stock
Options . Subject to approval
by the Compensation Committee, the Company shall grant to Executive
a nonqualified stock option (the “ Option ”) to
purchase 150,000 shares of the Company’s Common Stock, $0.001
par value per share (“Common Stock”). The Option
shall have an exercise price per share equal to the fair market
value on the date of grant (as determined by the Compensation
Committee after considering advice from an independent appraisal
firm) and shall be substantially in the form of
Exhibit 4.3 . The Option shall vest as to
25% of the shares issuable thereunder on the first anniversary of
the Effective Date, and the remainder shall vest in equal monthly
portions over the following 36 months, for a total four-year
vesting period, all as set forth in greater detail in the
Option. Notwithstanding the vesting schedule set forth above,
upon a Change of Control (as defined below), vesting of the Option
shall accelerate such that if a Change of Control occurs on or
before the first anniversary of the Effective Date, then 50% of the
shares issuable pursuant to the Option shall be immediately vested
and if a Change of Control occurs after the first anniversary of
the Effective Date, then all unvested shares issuable pursuant to
the Option shall immediately become vested.
For purposes of the Option, a
“ Change of Control ” shall mean the sale of all
or substantially all of assets or issued and outstanding capital
stock of the Company in one or more related transactions, or a
merger or consolidation involving the Company in which stockholders
of the Company immediately before such merger or consolidation do
not own immediately after such merger or consolidation capital
stock or other equity interests of the surviving corporation or
entity representing more than fifty percent in voting power of
capital stock or other equity interests of such surviving
corporation or entity outstanding immediately after such merger or
consolidation.
4.4.
Other
Benefits . Executive
shall have the right to participate in all benefit plans which may
be in effect for the Company’s executive employees from time
to time, including, without limitation, group health and dental
insurance, group life insurance, disability insurance, and
401(K) plans, in accordance with the terms and conditions
thereof.
4.5.
Expenses
. During
the term of this Agreement, the Company shall pay or reimburse
Executive for all reasonable and necessary out-of-pocket expenses
incurred by Executive in the performance of his duties under this
Agreement, subject to the presentment by Executive of appropriate
reports and receipts in accordance with the Company’s normal
policies for expense verification.
4.6.
Vacation
. Executive
shall be entitled to four weeks vacation each calendar year.
Any vacation taken by Executive shall be taken at such time as is
reasonably convenient in relationship to the needs of the business
of the Company. Vacation time shall not accrue beyond the
year in question; provided , however, that any vacation time
not taken during any year due to
3
constraints imposed by the
Company’s business requirements shall accrue beyond the year
in question.
5.
Restrictive
Covenants .
5.1.
Certain
Definitions . The following terms
shall have the following meanings:
“ Competitive Activity
” means the development, manufacture, distribution, sale or
marketing of products or services which compete with the
Company’s products or services, including without limitation
computer-mediated wound closure devices, imaging devices and
vascular devices, whether as a proprietor, partner, shareholder,
owner, employer, employee, independent contractor, venturer or
otherwise.
“ Competitor ”
means (i) Ethicon Endo-Surgery (currently a unit of
Johnson & Johnson), (ii) United Stated Surgical
Corporation (currently a unit of Tyco International’s Tyco
Healthcare division, which is soon to be spun out as an independent
company), (iii) any other Person (other than Company) that
engages in any Competitive Activity during the Restriction Period,
and (iv) any affiliate or successor of any of the foregoing
entities.
“ Confidential
Information ” means all confidential, secret or
proprietary information of or relating to the Company, its business
or practice, which is not generally known or available to the
public (whether or not in written or tangible form) including,
without limitation, designs, technology, customer lists, supplier
lists, processes, know-how, trade secrets, pricing policies and
other confidential business information.
“ Confidential
Materials ” means any and all documents, records,
reports, lists, notes, plans, materials, programs, software, disks,
diskettes, recordings, manuals, correspondence, memoranda, magnetic
media or any other tangible media (including, without limitation,
copies or reproductions of any of the foregoing) in which any
Confidential Information may be contained.
“ Customers ”
means any and all past, present and future customers of the
Company.
“ Company ” means
the Company and its subsidiaries, whether now or in the
future.
“ Non-Competition
Period ” means the period of time, commencing on the date
hereof and expiring 12 months after the termination of
Executive’s employment with the Company pursuant to, this
Agreement, voluntarily or involuntarily, for any reason whatsoever,
subject to extension pursuant to Section 5.6 below.
“ Person ” means
an individual, proprietorship, partnership, joint venture,
corporation, limited liability company, association, trust, estate,
unincorporated organization, a government or any branch,
subdivision, department or agency thereof, or any
entity.
4
“ Personnel ”
means any and all employees, contractors, agents, vendors,
consultants or other Persons rendering services or providing goods
to the Company for compensation in any form, whether employed by or
independent of the Company.
“ Restricted Area
” means world-wide.
“ Restriction Period
” means the period of time, commencing on the date hereof and
expiring 12 months after the termination of Executive’s
employment with the Company pursuant to, this Agreement,
voluntarily or involuntarily, for any reason whatsoever, subject to
extension pursuant to Section 5.4 below.
5.2.
Confidentiality
.
(a)
Confidential
Information . Subject to
Section 5.2(c):
(i)
Duty to
Maintain Confidentiality . Executive shall
maintain in strict confidence and duly safeguard to the best of his
ability any and all Confidential Information.
(ii)
Covenant Not
to Disclose, Use or Exploit . Executive shall not,
directly or indirectly, disclose, divulge or otherwise communicate
to anyone or use or otherwise exploit for the benefit of anyone,
other than the Company, any Confidential Information.
(iii)
Confidential
Materials . All Confidential
Information and Confidential Materials are and shall remain the
exclusive property of the Company and no such materials or
information may be copied or otherwise reproduced, removed from the
premises of the Company or entrusted to any Person (other than
Company itself or authorized Personnel) without prior written
permission from the Company.
(b)
Survival of
Covenants . Notwithstanding
anything herein to the contrary, the covenants set forth in this
Section 5.2 shall survive the termination of this Agreement
and any other agreement among the parties hereto (regardless of the
reason for such termination), unless terminated by a written
instrument that expressly terminates by specific reference the
covenants set forth in this Section 5.2.
(c)
Permitted
Activities . If Executive receives
a request or demand for Confidential Information (whether pursuant
to a discovery request, subpoena or otherwise), Executive shall
immediately give the Company written notice thereof and shall at
the Company’s expense (provided the Company approves any and
all such expenses) exert his best efforts to resist disclosure,
including, without limitation, by fully cooperating and assisting
the Company, at the Company’s expense, in whatever efforts it
may make to resist or limit disclosure or to obtain a protective
order or other appropriate remedy to limit or prohibit further
disclosure or use of such Confidential Information. If
Executive complies with the preceding sentence but nonetheless
becomes legally compelled to disclose Confidential Information,
Executive shall disclose only that portion of the Confidential
Information that he is legally compelled to disclose.
5
5.3.
Covenant not
to Compete . During the
Non-Competition Period, Executive shall not, directly, indirectly,
whether as a sole practitioner, owner, partner, shareholder,
investor, employee, Company, venturer, independent contractor,
consultant or other participant, (i) own, manage, invest in or
acquire any economic stake or interest in any Person involved in a
Competitive Activity, (ii) derive economic benefit from or
with respect to any Competitive Activity, or (iii) otherwise
engage or pa
|